Showing results (511-520 of 524) with videos related to

Sort By:
Pageof 53
Journal of Alzheimer'S Disease : JAD|August 25, 2020
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease PathologyLiu Shi, Laura M Winchester, Benjamine Y Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkersNiklas Mattsson, Ulf Andreasson, Staffan Persson, et al.
Human Mutation|December 24, 2016
TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral SclerosisJulie van der Zee, Ilse Gijselinck, Sara Van Mossevelde, et al.
Acta Neuropathologica|June 6, 2014
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degenerationJulie van der Zee, Tim Van Langenhove, Gabor G Kovacs, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumGanna Blazhenets, Heather M Snyder, Liana G Apostolova, et al.
Journal of Alzheimer'S Disease : JAD|November 14, 2025
Associations of lifestyle factors with amyloid pathology in persons without dementiaJulie E Oomens, Stephanie Jb Vos, Nancy N Maserejian, et al.
Nature Neuroscience|July 16, 2025
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sexRik Ossenkoppele, Emma M Coomans, Liana G Apostolova, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 31, 2018
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's diseaseNiklas Mattsson, Colin Groot, Willemijn J Jansen, et al.
JAMA Psychiatry|December 1, 2017
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without DementiaWillemijn J Jansen, Rik Ossenkoppele, Betty M Tijms, et al.
Pageof 53